Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. brain mri scan
Show results for
Products
Software
Applications

Companies

News
Articles

Refine by
Date

  • Older

Brain Mri Scan Articles & Analysis

4 news found

Oxford Brain Diagnostics’ grey matter quality measure selected as secondary outcome for Alzheimer’s Phase 2 clinical trial

Oxford Brain Diagnostics’ grey matter quality measure selected as secondary outcome for Alzheimer’s Phase 2 clinical trial

In the future, we hope this type of biomarker response will help predict a therapeutic benefit long before clinical benefits can be measured.” Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) ...

ByOxford Brain Diagnostics Ltd.


Oxford Brain Diagnostics establishes a research-based clinical MRI study in Japan to investigate how Cortical Disarray Measurement (CDM) analysis may support differential diagnosis and estimate disease severity in Dementia patients

Oxford Brain Diagnostics establishes a research-based clinical MRI study in Japan to investigate how Cortical Disarray Measurement (CDM) analysis may support differential diagnosis and estimate disease severity in Dementia patients

Brain imaging by MRI is available for patients with dementia and the prodromal stages using standard health insurance. ...

ByOxford Brain Diagnostics Ltd.


Oxford Brain Diagnostics wins funding from the National Institute for Health Research (NIHR) to test Alzheimer’s diagnostic in NHS

Oxford Brain Diagnostics wins funding from the National Institute for Health Research (NIHR) to test Alzheimer’s diagnostic in NHS

Alzheimer’s remains a complex condition so examining MRI scan data from the NHS at the earliest stages of the disease provides an opportunity to estimate patient prognosis, assess the future economic impact patients will have in long term care and more importantly provide valuable time to families in adjusting lifestyles and getting access to new drug ...

ByOxford Brain Diagnostics Ltd.


Oxford Brain Diagnostics awarded FDA Breakthrough Device Designation for technology to predict Alzheimer’s Disease

Oxford Brain Diagnostics awarded FDA Breakthrough Device Designation for technology to predict Alzheimer’s Disease

The CDM Software Device, used as an adjunct to other diagnostic evaluations, is intended to predict conversion from MCI to Alzheimer’s disease in patients previously diagnosed with MCI. CDM technology uses noninvasive MRI brain scan data linked to changes in the brain at a cellular level, offering sensitive and accurate ...

ByOxford Brain Diagnostics Ltd.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT